Cash flow Sana Biotechnology, Inc.

Stocks

SANA

US7995661045

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 19:52:21 11/06/2026 +03			5-day change	1st Jan Change
2.835 ^USD	+0.53%		-4.05%	-30.22%

06-10	Sana Biotechnology, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 04:00 PM
05-15	Sana Biotechnology Raises $69 Million Through ATM Equity Offering	MT

5a575da8282af8bae3fcf0.dcq5hH8sGjKM9tGTXWHmnn5cg-vzoI2AdFOvxYT2uPg.NpzqsiVbS3jZhYPxNBWy1hkGwYO0xuz4JWveieKU6Joip-jNNU4rfdPFvg

Published financial data: SANA BIOTECHNOLOGY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	50.41M	67.06M	73.3M	64.04M	44.3M
R&D Expenses	275M	204M	254M	207M	147M
Other Operating Expenses, Total	325M	271M	327M	271M	191M
Operating Income	-325M	-271M	-327M	-271M	-191M
Interest And Investment Income	676K	3.76M	9.94M	10.47M	3.85M
Net Interest Expenses	676K	3.76M	9.94M	10.47M	3.85M
Other Non Operating Income (Expenses)	305K	-674K	-52K	-	4.6M
EBT, Excl. Unusual Items	-324M	-268M	-317M	-261M	-183M
Merger & Related Restructuring Charges	-	-	-	-	-
Asset Writedown	-	-4.5M	-7.01M	-6.4M	-46.91M
Other Unusual Items	-31.84M	3.36M	40.77M	638K	-14.75M
EBT, Incl. Unusual Items	-356M	-269M	-283M	-267M	-244M
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-356M	-269M	-283M	-267M	-244M
Net Income to Company	-356M	-269M	-283M	-267M	-244M
Net Income - (IS)	-356M	-269M	-283M	-267M	-244M
Net Income to Common Incl Extra Items	-356M	-269M	-283M	-267M	-244M
Net Income to Common Excl. Extra Items	-356M	-269M	-283M	-267M	-244M
Per Share Items
Net EPS - Basic	-2.14	-1.43	-1.46	-1.16	-0.96
Basic EPS - Continuing Operations	-2.14	-1.43	-1.46	-1.16	-0.96
Basic Weighted Average Shares Outstanding	166M	188M	195M	231M	253M
Net EPS - Diluted	-2.14	-1.43	-1.46	-1.16	-0.96
Diluted EPS - Continuing Operations	-2.14	-1.43	-1.46	-1.16	-0.96
Diluted Weighted Average Shares Outstanding	166M	188M	195M	231M	253M
Normalized Basic EPS	-1.22	-0.89	-1.02	-0.71	-0.45
Normalized Diluted EPS	-1.22	-0.89	-1.02	-0.71	-0.45
Supplemental Items
EBITDA	-314M	-256M	-302M	-256M	-178M
EBITA	-325M	-271M	-327M	-271M	-191M
EBIT	-325M	-271M	-327M	-271M	-191M
EBITDAR	-292M	-225M	-268M	-224M	-141M
Effective Tax Rate - (Ratio)	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-203M	-168M	-198M	-163M	-114M
Supplemental Operating Expense Items
General and Administrative Expenses	50.41M	67.06M	73.3M	64.04M	44.3M
Research And Development Expense From Footnotes	306M	201M	220M	209M	161M
Net Rental Expense, Total	22.17M	31.07M	34.8M	31.71M	37.04M
Stock-Based Comp., R&D Exp. (Total)	15.24M	26.58M	23.24M	23.36M	15.19M
Stock-Based Comp., G&A Exp. (Total)	7.12M	11.75M	12.29M	14.31M	10.27M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	22.36M	38.34M	35.53M	37.68M	25.46M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	253M	177M	134M	128M	71.87M
Short Term Investments	298M	247M	71.68M	24.93M	66.51M
Total Cash And Short Term Investments	551M	424M	205M	152M	138M
Prepaid Expenses	7.1M	14.37M	4.49M	4.48M	6.1M
Restricted Cash	-	6.1M	3.83M	3.83M	4.2M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	558M	444M	214M	161M	149M
Gross Property Plant And Equipment	181M	193M	187M	189M	120M
Accumulated Depreciation	-18.77M	-33.98M	-41.77M	-54.17M	-54.76M
Net Property Plant And Equipment	162M	159M	146M	135M	65.22M
Long-term Investments	196M	10.05M	-	-	-
Goodwill	141M	141M	141M	141M	141M
Other Intangibles, Total	59.2M	59.2M	59.2M	59.2M	59.2M
Other Long-Term Assets, Total	13.82M	9.01M	6.37M	5.12M	3.17M
Total Assets	1.13B	823M	565M	501M	417M
Liabilities
Accounts Payable, Total	2.22M	2.86M	4.11M	5.21M	1.67M
Accrued Expenses, Total	28.91M	39.12M	37.98M	27.39M	21.52M
Current Portion of Leases	9.16M	12.39M	13.2M	12.83M	15.34M
Other Current Liabilities	58.95M	57.14M	9.2M	-	40.2M
Total Current Liabilities	99.24M	112M	64.49M	45.43M	78.73M
Long-Term Leases	102M	95.86M	90.9M	89.06M	70.92M
Other Non Current Liabilities	200M	116M	122M	116M	106M
Total Liabilities	401M	323M	278M	251M	256M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	18K	19K	20K	22K	27K
Additional Paid In Capital	1.52B	1.56B	1.63B	1.86B	2.01B
Retained Earnings	-785M	-1.05B	-1.34B	-1.6B	-1.85B
Comprehensive Income and Other	-1.37M	-4.33M	-60K	14K	28K
Total Common Equity	729M	499M	288M	251M	161M
Total Equity	729M	499M	288M	251M	161M
Total Liabilities And Equity	1.13B	823M	565M	501M	417M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	185M	191M	220M	225M	267M
ECS Total Common Shares Outstanding	185M	191M	198M	224M	267M
Book Value / Share	3.94	2.61	1.45	1.12	0.6
Tangible Book Value	529M	299M	87.68M	50.68M	-38.94M
Tangible Book Value Per Share	2.86	1.57	0.44	0.23	-0.15
Total Debt	111M	108M	104M	102M	86.26M
Net Debt	-636M	-326M	-101M	-50.6M	-52.12M
Debt Equivalent Oper. Leases	177M	249M	278M	254M	296M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	49M	64.76M	54.77M	57.79M	42.6M
Full Time Employees	383	418	328	194	142
Part Time Employees	3	3	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-356M	-269M	-283M	-267M	-244M
Depreciation & Amortization - CF	11.07M	15.62M	24.56M	15.5M	12.75M
Depreciation & Amortization, Total	11.07M	15.62M	24.56M	15.5M	12.75M
Asset Writedown & Restructuring Costs	-	-	-	1.89M	44.61M
Stock-Based Compensation (CF)	22.36M	38.34M	35.53M	37.68M	25.46M
Other Operating Activities, Total	61.64M	-82.08M	-49.03M	-10.28M	27.63M
Change In Accounts Payable	-266K	1.06M	1.03M	1.38M	-3.54M
Change in Other Net Operating Assets	10.07M	6.48M	17.58M	-2.56M	-6.57M
Cash from Operations	-251M	-290M	-254M	-223M	-144M
Capital Expenditure	-29.86M	-20.88M	-20.03M	-33.43M	-938K
Sale of Property, Plant, and Equipment	-	-	-	-	1.43M
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-211M	231M	192M	50.88M	-40.73M
Other Investing Activities, Total	-4.57M	-	-	-	-
Cash from Investing	-246M	211M	172M	17.45M	-40.24M
Long-Term Debt Issued, Total	-	-	-	7.74M	-
Total Debt Issued	-	-	-	7.74M	-
Long-Term Debt Repaid, Total	-	-	-	-	-347K
Total Debt Repaid	-	-	-	-	-347K
Issuance of Common Stock	632M	4.91M	31.65M	192M	129M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	632M	4.91M	31.65M	200M	129M
Net Change in Cash	135M	-74.58M	-49.92M	-5.95M	-55.33M
Supplemental Items
Levered Free Cash Flow	-138M	-141M	-200M	-169M	-53.57M
Unlevered Free Cash Flow	-138M	-141M	-200M	-169M	-53.57M
Change In Net Working Capital	-61.44M	4.33M	35.66M	18.68M	-28.51M
Net Debt Issued / Repaid	-	-	-	7.74M	-347K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-21.85	-17.38	-29.44	-31.82	-26
Return on Total Capital	-30.25	-23.45	-40.9	-45.61	-40.33
Return On Equity %	-61.36	-43.9	-72	-99.16	-118.7
Return on Common Equity	-231.63	-43.9	-72	-99.16	-118.7
Short Term Liquidity
Current Ratio	5.62	3.99	3.31	3.54	1.89
Quick Ratio	5.55	3.8	3.18	3.36	1.76
Operating Cash Flow to Current Liabilities	-2.53	-2.6	-3.93	-4.91	-1.83
Long Term Solvency
Total Debt/Equity	15.23	21.68	36.21	40.68	53.62
Total Debt / Total Capital	13.22	17.82	26.58	28.92	34.9
LT Debt/Equity	13.97	19.2	31.62	35.55	44.08
Long-Term Debt / Total Capital	12.13	15.78	23.21	25.27	28.7
Total Liabilities / Total Assets	35.5	39.31	49.14	50	61.41
Total Debt / EBITDA	-0.38	-0.48	-0.39	-0.45	-0.61
Net Debt / EBITDA	2.18	1.45	0.38	0.23	0.37
Total Debt / (EBITDA - Capex)	-0.34	-0.44	-0.36	-0.4	-0.61
Net Debt / (EBITDA - Capex)	1.98	1.33	0.35	0.2	0.37
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	38.06	-18.53	22.36	-17.26	-30.38
EBITA, 1 Yr. Growth %	39.3	-16.5	24.43	-16.96	-29.66
EBIT, 1 Yr. Growth %	39.3	-16.5	24.43	-16.96	-29.66
Earnings From Cont. Operations, 1 Yr. Growth %	24.75	-24.29	5.11	-5.82	-8.47
Net Income, 1 Yr. Growth %	24.75	-24.29	5.11	-5.82	-8.47
Normalized Net Income, 1 Yr. Growth %	39.38	-17.2	22.1	-17.67	-30.08
Diluted EPS Before Extra, 1 Yr. Growth %	-90.25	-33.1	1.76	-20.65	-16.55
Net Property, Plant and Equip., 1 Yr. Growth %	47.15	-1.47	-8.66	-7.09	-51.79
Total Assets, 1 Yr. Growth %	54.65	-27.15	-31.29	-11.37	-16.79
Tangible Book Value, 1 Yr. Growth %	-185.13	-43.35	-70.72	-42.2	-176.83
Common Equity, 1 Yr. Growth %	-272.97	-31.46	-42.42	-12.87	-35.78
Cash From Operations, 1 Yr. Growth %	81.95	15.53	-12.57	-12	-35.55
Capital Expenditures, 1 Yr. Growth %	25.09	-30.09	-4.04	66.88	-97.19
Levered Free Cash Flow, 1 Yr. Growth %	-7.36	1.97	47.59	-18.52	-68.17
Unlevered Free Cash Flow, 1 Yr. Growth %	-7.36	1.97	47.59	-18.52	-68.17
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	60.78	0.27	-1.87	0.03	-24.1
EBITA, 2 Yr. CAGR %	62.37	2.1	0.28	0.01	-23.57
EBIT, 2 Yr. CAGR %	62.37	2.1	0.28	0.01	-23.57
Earnings From Cont. Operations, 2 Yr. CAGR %	64.97	-2.81	-10.79	-0.51	-7.16
Net Income, 2 Yr. CAGR %	64.97	-2.81	-10.79	-0.51	-7.16
Normalized Net Income, 2 Yr. CAGR %	64.02	1.69	-1.1	-1.38	-24.13
Diluted EPS Before Extra, 2 Yr. CAGR %	-71.68	-74.45	-17.49	-10.14	-18.62
Net Property, Plant and Equip., 2 Yr. CAGR %	53.34	20.41	-5.14	-7.88	-33.07
Total Assets, 2 Yr. CAGR %	64.93	6.14	-29.25	-21.96	-14.12
Tangible Book Value, 2 Yr. CAGR %	24.27	-30.55	-59.27	-58.86	-33.36
Common Equity, 2 Yr. CAGR %	126.07	8.88	-37.18	-29.17	-25.19
Cash From Operations, 2 Yr. CAGR %	71.34	44.99	0.5	-12.29	-24.69
Capital Expenditures, 2 Yr. CAGR %	6.92	-6.49	-18.1	26.54	-78.36
Levered Free Cash Flow, 2 Yr. CAGR %	26.03	-7.88	20.29	9.39	-49.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.03	-7.88	20.29	9.39	-49.12
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	128.01	28.18	5.92	-6.58	-11.35
EBITA, 3 Yr. CAGR %	130.65	30.09	7.88	-5.83	-11.06
EBIT, 3 Yr. CAGR %	130.65	30.09	7.88	-5.83	-11.06
Earnings From Cont. Operations, 3 Yr. CAGR %	137.72	27.25	-0.24	-9.17	-3.23
Net Income, 3 Yr. CAGR %	137.72	27.25	-0.24	-9.17	-3.23
Normalized Net Income, 3 Yr. CAGR %	130.41	30.6	6.9	-6.96	-12.06
Diluted EPS Before Extra, 3 Yr. CAGR %	-57.49	-62.29	-59.5	-18.56	-12.33
Net Property, Plant and Equip., 3 Yr. CAGR %	551.52	32.32	9.81	-5.79	-25.76
Total Assets, 3 Yr. CAGR %	220.42	25.6	-8.18	-23.73	-20.28
Tangible Book Value, 3 Yr. CAGR %	242.25	-4.36	-47.93	-54.23	-49.34
Common Equity, 3 Yr. CAGR %	280.85	51.87	-11.95	-29.94	-31.44
Cash From Operations, 3 Yr. CAGR %	110.31	50.25	22.49	-3.85	-20.85
Capital Expenditures, 3 Yr. CAGR %	218.99	-7.2	-5.68	3.83	-64.45
Levered Free Cash Flow, 3 Yr. CAGR %	-	17.44	6.39	6.86	-27.56
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	17.44	6.39	6.86	-27.56
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	62.74	16.08	-6.87
EBITA, 5 Yr. CAGR %	-	-	65.3	17.1	-6.01
EBIT, 5 Yr. CAGR %	-	-	65.3	17.1	-6.01
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	60.62	15.32	-3.07
Net Income, 5 Yr. CAGR %	-	-	60.62	15.32	-3.07
Normalized Net Income, 5 Yr. CAGR %	-	-	64.28	16.72	-6.8
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-44.57	-46.63	-46.46
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	201.44	14.48	-9.92
Total Assets, 5 Yr. CAGR %	-	-	75.11	3.83	-10.61
Tangible Book Value, 5 Yr. CAGR %	-	-	46.07	-31.75	-42.53
Common Equity, 5 Yr. CAGR %	-	-	85.22	11.94	-17.51
Cash From Operations, 5 Yr. CAGR %	-	-	56.52	21.15	0.83
Capital Expenditures, 5 Yr. CAGR %	-	-	85.18	5.06	-47.66
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	14.15	-20.25
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	14.15	-20.25